Stock PCSA PROCESSA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Processa Pharmaceuticals, Inc.

Equities

PCSA

US74275C3043

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.96 USD -2.00% Intraday chart for Processa Pharmaceuticals, Inc. -6.22% -70.71%
May. 10 Processa Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 Processa Pharmaceuticals, Inc. Names Steven Cha as Senior Vice President of Clinical Research CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Processa Pharmaceuticals, Inc. - Special Call
Transcript : Processa Pharmaceuticals, Inc., 2022 Earnings Call, Mar 30, 2023
Transcript : Processa Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 08, 2022
Transcript : Processa Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 11, 2022
Transcript : Processa Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
Transcript : Processa Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 30, 2022
Transcript : Processa Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 12, 2020
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PCSA Stock
  4. News Processa Pharmaceuticals, Inc.
  5. Transcripts
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW